,

Shixue Sun1, Zeenat Shyr2, Kathleen McDaniel2

  • 1Informatics Core, Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD, USA.

PubMed
概括

这项研究开发了一个计算管道,以确定潜在的质母细胞瘤 (GBM) 药物. 克洛法拉宾和西克洛皮洛克斯被证实有效向GBM癌细胞,为罕见疾病药物开发提供了希望.